Michael Markus
Internal Medicine · Fairfield Township, OHNPI 1740246297
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,023 and has fallen 97.6% since, to $25 in 2022.
Across 120 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$313
- AstraZeneca$258
- Novo Nordisk$181
- Pfizer$146
- Lilly USA, LLC$141
- Boehringer Ingelheim$120
- plus $614 from 17 others
What the payments were for
- Food & beverage$1,767100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $313 |
| AstraZeneca | 13 | $258 |
| Novo Nordisk | 11 | $181 |
| Pfizer | 15 | $146 |
| Lilly USA, LLC | 9 | $141 |
| Boehringer Ingelheim | 8 | $120 |
| Amgen | 4 | $78 |
| Kowa Pharmaceuticals America, Inc. | 6 | $77 |
| Merck | 5 | $66 |
| Sanofi-aventis U.S. LLC | 4 | $59 |
| Astellas Pharma US Inc | 3 | $50 |
| GSK | 3 | $48 |
| Johnson & Johnson | 3 | $41 |
| Clarus Therapeutics Inc. | 4 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Biohaven Pharmaceuticals, Inc. | 2 | $26 |
| Abbott | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Circassia Inc. | 1 | $13 |
| Acerus Pharmaceuticals Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,773 in reported general payments places this provider in the 80th percentile of 4,428 internal medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Simvastatin | 11 | $165 |
| Hydrochlorothiazide | 12 | $4 |
| Amlodipine Besylate | 16 | $2 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Fairfield Township
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.